Table 5 Summary of results for non-IRs: Antibiotics and Local Anesthetics
ST+ | ST- | DPT+ | DPT- | DPT Alt. Neg | DPT Alt. Pos | |
|---|---|---|---|---|---|---|
BLs (no. 234) | ||||||
Skin Reactions (no. 225) | 3/225 (1.3%) | 182/225 (80.9%) | 14/225 (6.2%) | 157/225 (69.8%) | 9/225 (4%) | – |
Respiratory Symptoms (no. 1) | ||||||
-Bronchospasm (no. 1) | – | 1/1 (100%) | – | 1/1 (100%) | – | – |
SJS (no. 4) | 1/4 (25%) | 3/4 (75%) | – | – | – | – |
DRESS (no. 2) | 1/2 (50%) | 1/2 (50%) | – | – | – | – |
SSLR (no. 1) | – | – | – | – | – | – |
Thrombocytopenia (no. 1) | – | 1/1 (100%) | – | 1/1 (100%) | – | – |
Macrolides (no. 35) | ||||||
Skin Reactions (no. 34) | 8/34 (23.5%) | 21/34 (61.7%) | – | 19/34 (55.9%) | 2/34 (5.9%) | 1/34 (2.9%) |
Hypothermia (no. 1) | – | 1/1 (100%) | – | 1/1 (100%) | – | – |
Glycopeptides (no. 2) | ||||||
Skin reactions (no. 2) | – | 2/2 (100%) | – | – | – | – |
Trimethoprim Sulfamethoxazole (n °4) | ||||||
Skin reactions (no. 4) | – | 3/4 (75%) | – | 1/4 (25%) | – | – |
Fluoroquinolones (no. 1) | ||||||
Skin reactions (no. 1) | – | 1/1 (100%) | – | 1/1 (100%) | – | – |
Local Anesthetics (no. 13) | ||||||
Skin Reactions (no. 13) | – | 11/13 (84.6%) | 1/13 (7.7%) | 10/13 (76.9%) | – | – |